News

CSL Biotherapies has received FDA approval for its seasonal flu vaccine, Afluria (Influenza Virus Vaccine) for use in the pediatric population aged 6 months and older. This approval

Sanofi Pasteur has reported the final analyses of data from clinical trials of the US licensed Influenza A (H1N1) 2009 Monovalent Vaccine in adults and children. Reportedly, the

Roxane Laboratories (Roxane) has received approval for its Abbreviated New Drug Application (ANDA) for Perindopril Erbumine tablets, 2mg, 4mg and 8mg from the FDA. Perindopril Erbumine tablets are

Antares Pharma (Antares) has entered into a license and an asset purchase agreement with Ferring International Center. Under the terms of the exclusive license agreement Ferring obtained rights

The Bend Memorial Clinic is enrolling patients for a MAGRIT (MAGE-A3 as Adjuvant Non-Small Cell LunG CanceR ImmunoTherapy) Phase III lung cancer trial aimed at preventing the disease’s

LecTec has reached a settlement with Endo Pharmaceuticals on outstanding patent litigation related to LecTec’s US Patent Nos 5536263 and 5741510. Endo Pharmaceuticals has agreed to make a

Genmab has posted revenues of $86m for the nine month period ended September 30, 2009. In the same period of 2008, Genmab recognised revenues of $131m. An operating

Ryogen has been awarded a new patent titled ‘Isolated Genomic Polynucleotide Fragments from Chromosome 7’. US patent No 7588915 has been issued by the US Patent and Trademark

Geron has presented new data showing that oligodendrocyte progenitor cells (OPCs) derived from human embryonic stem cells (hESCs), when transplanted into a rodent model of cervical spinal cord